| 1UVS: reference: Enzyme flexibility, solvent and 'weak' interactions characterize thrombin-ligand interactions: implications for drug design., Engh RA, Brandstetter H, Sucher G, Eichinger A, Baumann U, Bode W, Huber R, Poll T, Rudolph R, von der Saal W, Structure 1996 Nov 15;4(11):1353-62. PMID: 8939759 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).